🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Conrad Fischer Amer Zeidan MBBS,MHS ‏عامر زيدان FSMB NBME ECFMG for IMGs Bryan Carmody In 2007 i applied to every single pathology program (except TX). A lot of application fees💰 4 an unemployed #IMG. W/ 99/99 (254/279) USMLE scores I got <10 interviews 😒 my flaw: being an IMG! the system is stacked against IMGs. We must do better and act, not just talk #DEI

Extended letermovir prophylaxis in R+ allohsct population to 200 days showing rebound csCMVi once prophylaxis stops. No statistical benefit at week 48. #ECCMID23 #ECCMID2023. #TID NCIC #CMV

Daniel Auclair . We should never watch and wait??? Patients read twitter posts- we need to be careful distinguishing clinical investigations from management recommendations.

Great Work by Dr. Amer Zeidan MBBS,MHS ‏عامر زيدان & The myeloid Consortium. It is truly an urging need now, for such a change. Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes ashpublications.org/blood/article-… #mdssm #mds2023

Don’t miss this important conference. CME, ABIM MOC points available. Networking opportunities with regional experts

Join us for a Genitourinary Cancer Session at Best of ASCO 2023, Boise with Dr. David Gill (of Intermountain Health), Umang Swami, MD, MSCI, FASCO (of Huntsman Cancer Institute), and Benjamin L Maughan (of Huntsman Cancer Institute )! #BestofASCO ➡️REGISTER: education.binayfoundation.org/content/best-a… #CME #Oncology #Boise

Anticipating all that Prashant Sharma, MD, FACP (Intermountain Health), @MyelomaSLC (Huntsman Cancer Institute), and Dr. Wayne Ormsby (Utah Cancer Specialists) will share at Best of ASCO 2023, Boise! Don't miss this session and others July 15-16, 2023. ➡️REGISTER: education.binayfoundation.org/content/best-a… #BestofASCO #CME #Oncology

Toxic cultures exploit generosity. Takers impose extra work on givers, and no good deed goes unpunished. Healthy cultures reward generosity. People protect givers from takers, and cream rises to the top. Helpfulness is not a weakness to target. It's a strength to safeguard.

On my way to Beyond Trauma Foundation Best of ASCO, Boise ID. Looking forward to seeing colleagues in Idaho. Mark Lewis, MD, FASCO Prashant Sharma, MD, FACP Umang Swami, MD, MSCI, FASCO Benjamin L Maughan Sonam Puri MD

Such amazing speakers at #BestofASCO 2023, Boise GI session moderated by Dr. Stephanie Hodson. Mark Lewis, MD, FASCO (Intermountain Health), Ignacio Garrido-Laguna (Huntsman Cancer Institute), & Dr. Glynn Gilcrease (Huntsman Cancer Institute) left us with notable updates through memorable presentations!

A wonderful Breast Cancer Session moderated by Dr. Banu Symington with Mei Wei, MD (Huntsman Cancer Institute), Shivani Shinde (Intermountain Health), and Dr. Christos Vaklavas (Huntsman Cancer Institute) to wrap up #BestofASCO 2023, Boise! Truly so informative and a great end to this conference.

If you are a clinician rotating through the hematology clinic and seeing patients with plasma cell dyscrasias, here are 10 applications/calculators that will be of much help to you in your clinic! I have links to each app, and also why I use them. #mmsm 🧵 1/

CONGRESS| #SOHO2023 In the smoldering MM: Time to Watch and Wait session Angela Dispenzieri debates how to treat patients with high-risk smoldering MM based on OS data that may have been contaminated with actual MM patients and if it is ethical to treat low and intermediate risk who

She believed she could but it was uncompensated, non promotable work she had no interest in so she set a reasonable boundary, protected her time, and said no.

Its mostly no different than donating blood, but South Asian Blood cancer patients needing donor marrow are far less likely to find a match than most other ethnic groups because we make up <3% of the NMDP registry. Please consider becoming a donor - just takes a cheek swab!

To all heme onc health care folks hope you can make this. Also MOC available. This weekend

Anitocel presented 40 enrolled and 38 dosed. 100M cells. Prior LOT 5-4. ORR 100% 76% CR or better, across all groups. Median PFS not reached at 2 years. Not even in EMD group. No clear HR genetics influence ORR. No MNT. iMMagjne-3 trial similar to CARTITUDE-4 #IMS24RF #mmsm

#ASH24 #mmsm Few important observations on AQUILA This is in top of prior observations I shared 🧵

An U.S. FDA ODAC will be held May 20th to discuss the potential approval for Dara in smoldering myeloma #mmsm Very good points made in the discussion 👇 ➡️ fda.gov/media/186527/d… Few important observations summarised here🧵